OncoMed raises $55M in follow-on

Cancer stem cell company OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) raised $55 million through the sale

Read the full 149 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE